We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVNT icon
751
Avient
AVNT
$3.41B
$811K 0.02%
25,517
+5,086
+25% +$170K
AVY icon
752
Avery Dennison
AVY
$12.9B
$811K 0.02%
+12,942
New +$817K
DAL icon
753
CALL
Delta Air Lines
DAL
$58.8B
$811K 0.02%
16,000
-25,100
-61% -$1.24M
DAL icon
754
PUT
Delta Air Lines
DAL
$58.8B
$811K 0.02%
16,000
-25,100
-61% -$1.24M
PINC
755
DELISTED
Premier
PINC
$808K 0.02%
22,924
+15,194
+197% +$529K
SC
756
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$807K 0.02%
50,880
+40,215
+377% +$735K
GNC
757
DELISTED
GNC Holdings, Inc.
GNC
$805K 0.02%
25,929
-1,975
-7% -$66.5K
AHL
758
DELISTED
ASPEN Insurance Holding Limited
AHL
$805K 0.02%
16,681
+3,987
+31% +$196K
JCI icon
759
Johnson Controls International
JCI
$85.6B
$804K 0.02%
+19,444
New +$879K
PDM
760
Piedmont Realty Trust
PDM
$1.2B
$804K 0.02%
42,570
+32,169
+309% +$615K
FELE icon
761
Franklin Electric
FELE
$4.85B
$803K 0.02%
+29,687
New +$896K
CIT
762
DELISTED
CIT Group Inc.
CIT
$803K 0.02%
20,208
-24,445
-55% -$1.03M
WOLF icon
763
Wolfspeed
WOLF
$1.14B
$800K 0.02%
+30,000
New +$775K
CLGX
764
DELISTED
Corelogic, Inc.
CLGX
$799K 0.02%
23,578
+7,098
+43% +$265K
LEG icon
765
Leggett & Platt
LEG
$1.47B
$796K 0.02%
18,956
-5,765
-23% -$256K
TT icon
766
Trane Technologies
TT
$104B
$795K 0.02%
14,349
-15,660
-52% -$881K
GIS icon
767
General Mills
GIS
$20.1B
$793K 0.02%
13,760
-44,824
-77% -$2.58M
KMB icon
768
Kimberly-Clark
KMB
$37.5B
$793K 0.02%
6,223
-4,035
-39% -$484K
NCLH icon
769
Norwegian Cruise Line
NCLH
$9.74B
$793K 0.02%
13,540
+157
+1% +$9.24K
TTEK icon
770
Tetra Tech
TTEK
$8.7B
$793K 0.02%
152,435
+24,325
+19% +$130K
AN icon
771
AutoNation
AN
$7.37B
$790K 0.02%
13,249
-1,726
-12% -$107K
HIW icon
772
Highwoods Properties
HIW
$3.71B
$788K 0.02%
18,073
+6,440
+55% +$275K
KMI icon
773
Kinder Morgan
KMI
$70.3B
$788K 0.02%
52,849
+11,986
+29% +$286K
WOR icon
774
Worthington Enterprises
WOR
$2.82B
$786K 0.02%
42,281
-25,248
-37% -$467K
BAC icon
775
Bank of America
BAC
$439B
$784K 0.02%
46,555
-122,867
-73% -$2.08M

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.